Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pfeifer

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|December 16, 2010
Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 speciesAsad Jan, Oskar Adolfsson, Igor Allaman, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer's diseaseNampally Sreenivasachary, Heiko Kroth, Pascal Benderitter, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2016
Synthesis and structure-activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of β-amyloid-42 aggregationHeiko Kroth, Nampally Sreenivasachary, Anne Hamel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentLara Herriott, Mark Coles, Eamonn Gaffney, et al.
Nuclear Medicine and Biology|December 6, 2011
Fluorine-18 labeling of three novel D-peptides by conjugation with N-succinimidyl-4-[18F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiographyMahabuba Jahan, Sangram Nag, Raisa Krasikova, et al.
Acta Neuropathologica Communications|October 4, 2024
Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTDElodie Chevalier, Mickael Audrain, Monisha Ratnam, et al.
Neurochemistry International|November 22, 2011
Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patientsBalázs Gulyás, Christian Spenger, Zsuzsa Beliczai, et al.
Plos One|August 1, 2012
Development of a small D-enantiomeric Alzheimer's amyloid-β binding peptide ligand for future in vivo imaging applicationsSusanne Aileen Funke, Dirk Bartnik, Julian Marius Glück, et al.
Frontiers in Neuroscience|July 14, 2023
Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behaviorCassia Overk, Emma Fiorini, Chiara Babolin, et al.
Journal of Alzheimer'S Disease : JAD|December 31, 2016
Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy EpitopeClara Theunis, Oskar Adolfsson, Natalia Crespo-Biel, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|December 16, 2010
Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 speciesAsad Jan, Oskar Adolfsson, Igor Allaman, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer's diseaseNampally Sreenivasachary, Heiko Kroth, Pascal Benderitter, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2016
Synthesis and structure-activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of β-amyloid-42 aggregationHeiko Kroth, Nampally Sreenivasachary, Anne Hamel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentLara Herriott, Mark Coles, Eamonn Gaffney, et al.
Nuclear Medicine and Biology|December 6, 2011
Fluorine-18 labeling of three novel D-peptides by conjugation with N-succinimidyl-4-[18F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiographyMahabuba Jahan, Sangram Nag, Raisa Krasikova, et al.
Acta Neuropathologica Communications|October 4, 2024
Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTDElodie Chevalier, Mickael Audrain, Monisha Ratnam, et al.
Neurochemistry International|November 22, 2011
Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patientsBalázs Gulyás, Christian Spenger, Zsuzsa Beliczai, et al.
Plos One|August 1, 2012
Development of a small D-enantiomeric Alzheimer's amyloid-β binding peptide ligand for future in vivo imaging applicationsSusanne Aileen Funke, Dirk Bartnik, Julian Marius Glück, et al.
Frontiers in Neuroscience|July 14, 2023
Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behaviorCassia Overk, Emma Fiorini, Chiara Babolin, et al.
Journal of Alzheimer'S Disease : JAD|December 31, 2016
Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy EpitopeClara Theunis, Oskar Adolfsson, Natalia Crespo-Biel, et al.
Pageof 6